arrow
K

Klaus G. Parhofer

university of munich
H指数:62
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies

使用PCSK9单克隆抗体的心血管风险极高的患者的治疗持久性,降脂和3年临床结果

2025-08-040
OA
Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment

关于将联合治疗整合到血脂异常的治疗算法中的专家意见: 依泽替米贝和bempedoic酸的整合可能会提高目标的实现

2025-03-010
PRE
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
2023-06-0140
OAAI
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
2023-05-0289
OAAI
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

脂蛋白 (a) 在动脉粥样硬化性心血管疾病和主动脉瓣狭窄中的作用: 欧洲动脉粥样硬化学会共识声明

2022-08-18447
OAAI